To tackle the public health crisis of Alzheimer’s disease (AD) and other diseases, we must work together. Through the Charleston Conference on Alzheimer’s Disease (CCAD), New Vision Research (NVR) draws from over 50 universities across the United States to help ensure early-career scientists are collaborating, advancing their research and successfully pursuing funding opportunities for their innovative ideas.
The New Vision Investigator Award and New Vision Scholar Award have provided seed funding to over twenty early-career investigators who have gone on to receive significant NIH grants – boosting their careers and bringing prestige to their institutions. Also, individuals who attend NVR’s CCAD have subsequently collaborated to secure additional funding together.
New Vision Research fosters cross-pollination among scientists from different educational institutions and organizations, leading to improvements in diagnosis, treatment, and ultimately a cure for Alzheimer’s disease through CCAD, and hopefully other diseases through future conferences.